Nagpur, Maharashtra
GST No. 27AEPFS7579K1ZW
Call 08047302413 67% Response Rate
Send Enquiry
| Strength | 150 mg |
| Compostion | Nintedanib (150mg) |
| Country of Origin | Made in India |
| Brand | Nintib-150 |
| Uses | Idiopathic Pulmonary fibrosis / Non-small cell lung cancer |
| Form Type | Capsule |
| Packaging Size | 30 Capsules per Bottle |
View Complete details
| Dose/Strength | 250 mg |
| Form | Tablet |
| Manufactured By | Pfizer Ltd |
| Compostion | Crizotinib (250mg) |
| Country of Origin | Made in India |
| Treatment | Non-small cell lung cancer |
View Complete details
Minimum Order Quantity: 10 Stripe
| Strength | 75 mg |
| Form | Capsule |
| Composition | Oseltamivir |
| Brand | Oseltamivir |
| Manufactured By | Cipla |
| Shelf Life | 3 Years |
| Packaging Size | Box |
| Packaging Type | Strip |
View Complete details
| Strength / Dose | 4 mg |
| Packaging Type | Strip |
| Packaging Size | 28 Tablets |
| Brand | Olumiant |
| Shelf life | 24 Months |
View Complete details
| Strength | 50 mg |
| Form | Tablet |
| Compostion | Sunitinib (50mg) |
| Country of Origin | Made in India |
| Packaging Size | 28 Capsules |
| Manufacturer | Natco Pharma Ltd |
| Treatment | Kidney cancer, Gastrointestinal stromal tumour |
| Brand | Sutinat-50 |
| Shelif Life | 24 Year |
View Complete details
| Strength | 60 mg |
| Pack Size | 30 Tablets |
| Form | Tablet |
| Country of Origin | Made in India |
| Composition | Cabozatinib |
View Complete details
| Strength | 1 mg |
| Form | Tablet |
| Country of Origin | Made in India |
| Composition | Pomalidomide |
| Type | Bottle |
View Complete details
| Packaging Size | 6*7 tablet |
| Strength | 4.45mg/11.8mg |
| Form | Tablet |
| Manufacturer | Natco |
| Brand | Tegonat |
| Treatment | Advanced stomach cancer |
View Complete details
| Strength | 3.75 mg |
| Packaging Size | 2 ml |
| Brand | Lupride |
| Manufacturer | Sun Pharmaceutical Industries Ltd |
| Shelf Life | 24 months |
| Storage Instructions | Store at temperature not exeeding 25*C,protected from light Do not freez. |
View Complete details